Bleeding and thrombotic events in patients with colorectal cancer treated with bevacizumab and receiving novel oral anticoagulants and antiplatelet medications.

被引：0
|
作者：
Rho, Shinji
Wang, Chris
Dehkordi, Seyed Hamed Hosseini
Sears, Jerod J.
Hu, Zishuo Ian
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
104
引用
收藏
页码：104 / 104
页数：1
相关论文
共 45 条
  • [31] The incidence of major bleeding in adult patients with urogenital and gynecological cancer being treated with direct oral anticoagulants (DOACs): a systematic review
    L. Al-Tourah
    S. Mithoowani
    W Lim
    Rick Ikesaka
    Journal of Thrombosis and Thrombolysis, 2024, 57 : 630 - 637
  • [32] Mortality, Recurrent Thromboembolism and Major Bleeding in Cancer-Associated and Non-Cancer Pulmonary Embolism Patients Treated With Direct Oral Anticoagulants
    Nakano, Yoshihisa
    Adachi, Shiro
    Imai, Ryo
    Yoshida, Masahiro
    Shimokata, Shigetake
    Murohara, Toyoaki
    Kondo, Takahisa
    CIRCULATION JOURNAL, 2024, 88 (02) : 243 - 250
  • [33] Bevacizumab use and risk of cardiovascular adverse events among elderly patients with colorectal cancer receiving chemotherapy: a population-based study
    Tsai, H. -T.
    Marshall, J. L.
    Weiss, S. R.
    Huang, C. -Y.
    Warren, J. L.
    Freedman, A. N.
    Fu, A. Z.
    Sansbury, L. B.
    Potosky, A. L.
    ANNALS OF ONCOLOGY, 2013, 24 (06) : 1574 - 1579
  • [34] Risk of Recurrent Venous Thromboembolism and Bleeding in Cancer Patients Treated With Direct Oral Anticoagulants Versus Low-molecular-weight Heparin
    Long, Brit
    Koyfman, Alex
    Gottlieb, Michael
    ACADEMIC EMERGENCY MEDICINE, 2020, 27 (02) : 170 - 172
  • [35] Major bleeding, hospitalisation rates and healthcare costs among non-valvular atrial fibrillation patients naive to oral anticoagulation and newly treated with novel oral anticoagulants
    Deitelzweig, S.
    Bruno, A.
    Tate, N.
    Ogbonnaya, A.
    Shah, M.
    Farrelly, E.
    Lokhandwala, T.
    Gupta, K.
    Eaddy, M.
    EUROPEAN HEART JOURNAL, 2015, 36 : 338 - 338
  • [36] Incidence of serious bleeding events (sBE) in patients (pts) with metastatic colorectal cancer (mCRC) receiving bevacizumab (BV) as part of a first-line regimen: Results from the BRiTE observational cohort study (OCS)
    Flynn, P. J.
    Sugrue, M. M.
    Feng, S.
    Purdie, D. M.
    Grothey, A.
    Sargent, D. J.
    Berlin, J. D.
    Kabbinavar, F. F.
    Dong, W.
    Kozloff, M. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [37] Serious arterial thromboembolic events (sATE) in patients (PTS) with metastatic colorectal cancer (MCRC) treated with bevacizumab (BV): Results from the BRiTE registry
    Sugrue, M.
    Yi, J.
    Purdie, D.
    Dong, W.
    Grothey, A.
    Kozoff, M.
    ANNALS OF ONCOLOGY, 2007, 18 : VII30 - VII30
  • [38] Serious arterial thromboembolic events (sATE) in patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizumab (BV): Results from the BRiTE registry
    Sugrue, M. M.
    Yi, J.
    Purdie, D.
    Dong, W.
    Grothey, A.
    Kozloff, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [39] Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry
    Mei, Davide Antonio
    Imberti, Jacopo Francesco
    Bonini, Niccolo
    Romiti, Giulio Francesco
    Corica, Bernadette
    Proietti, Marco
    Vitolo, Marco
    Lip, Gregory Y. H.
    Boriani, Giuseppe
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 128 : 63 - 70
  • [40] Clustering of ABCB1 and CYP2C19 Genetic Variants Predicts Risk of Major Bleeding and Thrombotic Events in Elderly Patients with Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel
    Roberta Galeazzi
    Fabiola Olivieri
    Liana Spazzafumo
    Giuseppina Rose
    Alberto Montesanto
    Simona Giovagnetti
    Sara Cecchini
    Gelsomina Malatesta
    Raffaele Di Pillo
    Roberto Antonicelli
    Drugs & Aging, 2018, 35 : 649 - 656
12345